Table 4 Standardized betas of multiple linear regression analyses and logistic linear regression analyses evaluating the association of independent variables with HRQoL and psychological distress across all cancers (n = 5249)

Age

−0.21 (−0.28 to −0.15)

−0.25 (−0.31 to −0.18)

−0.17 (−0.25 to −0.09)

−0.12 (−0.19 to −0.05)

0.20 (0.12 to 0.28)

0.27 (0.19 to 0.35)

1.01 (1.00 to 1.02)

1.01 (1.01 to 1.02)

Sex

−1.13 (−2.90 to 0.63)

−0.91 (−2.64 to 0.82)

−3.15 (−5.18 to −1.13)

0.73 (−1.01 to 2.47)

0.44 (−1.50 to 2.38)

1.16 (−0.79 to 3.11)

1.43 (1.24 to 1.62)

1.20 (1.02 to 1.37)

Marital status

0.65 (−1.17 to 2.48)

1.94 (0.16 to 3.73)

2.22 (0.13 to 4.31)

1.36 (−0.44 to 3.15)

−1.42 (−3.42 to 0.59)

−2.04 (−4.05 to −0.03)

1.18 (0.98 to 1.37)

0.93 (0.75 to 1.12)

 Primary

Ref

Ref

Ref

Ref

Ref

Ref

Ref

Ref

 Secondary

−2.70 (−4.55 to −0.86)

−2.17 (−3.98 to −0.37)

−5.16 (−7.27 to −3.04)

−5.63 (−7.45 to −3.81)

3.17 (1.14 to 5.20)

4.39 (2.36 to 6.43)

2.24 (2.04 to 2.44)

1.79 (1.60 to 1.97)

 Tertiary

−4.07 (−6.30 to −1.84)

−2.82 (−5.00 to −0.63)

−6.04 (−8.60 to −3.48)

−3.68 (−5.88 to −1.48)

3.48 (1.02 to 5.94)

5.44 (2.97 to 7.90)

1.81 (1.56 to 2.05)

1.34 (1.12 to 1.57)

 Low

Ref

Ref

Ref

Ref

Ref

Ref

Ref

Ref

 Medium

−0.83 (−2.90 to 1.24)

−0.20 (−2.23 to 1.83)

0.87 (−1.50 to 3.24)

−0.39 (−2.43 to 1.65)

0.22 (−2.06 to 2.50)

−0.27 (−2.56 to 2.01)

0.90 (0.68 to 1.11)

1.18 (0.98 to 1.39)

 High

3.68 (1.78 to 5.58)

2.51 (0.64 to 4.37)

2.75 (0.57 to 4.94)

−0.09 (−1.97 to 1.79)

−2.49 (−4.59 to −0.39)

−0.39 (−2.49 to 1.71)

0.48 (0.28 to 0.69)

0.74 (0.55 to 0.93)

 Health insurance

1.16 (−0.47 to 2.79)

−2.21 (−3.80 to −0.62)

0.09 (−1.78 to 1.96)

2.46 (0.85 to 4.06)

3.88 (2.09 to 5.67)

3.74 (1.94 to 5.54)

1.13 (0.95 to 1.30)

1.21 (1.05 to 1.38)

 Economic hardship

−0.63 (−2.23 to 0.98)

−3.28 (−4.86 to −1.71)

−2.35 (−4.19 to −0.50)

2.44 (0.86 to 4.03)

3.41 (1.64 to 5.18)

3.85 (2.07 to 5.62)

0.81 (0.64 to 0.99)

0.94 (0.78 to 1.10)

 Paid work

2.04 (0.40 to 3.68)

3.11 (1.50 to 4.72)

1.72 (−0.16 to 3.60)

2.76 (1.14 to 4.37)

−3.17 (−4.98 to −1.37)

−3.25 (−5.06 to −1.44)

0.66 (0.48 to 0.83)

0.68 (0.51 to 0.84)

 Stage I

Ref

Ref

Ref

Ref

Ref

Ref

 Stage II

−1.43 (−4.06 to 1.20)

−2.09 (−4.66 to 0.48)

−1.37 (−4.38 to 1.65)

−2.14 (−4.73 to 0.45)

2.96 (0.07 to 5.86)

2.79 (−0.11 to 5.69)

1.30 (1.00 to 1.60)

1.12 (0.86 to 1.39)

 Stage III

−3.42 (−6.18 to −0.66)

−4.45 (−7.15 to −1.75)

−4.77 (−7.94 to −1.61)

−4.09 (−6.81 to −1.37)

6.32 (3.29 to 9.36)

5.97 (2.93 to 9.02)

1.30 (0.99 to 1.61)

1.21 (0.93 to 1.49)

 Stage IV

−13.34 (−16.40 to −10.27)

−14.73 (−17.73 to −11.73)

−18.61 (−22.13 to −15.10)

−15.14 (−18.16 to −12.11)

19.29 (15.91 to 22.67)

20.01 (16.63 to 23.40)

2.73 (2.40 to 3.07)

2.29 (1.98 to 2.60)

 Hematological

−8.53 (−12.07 to −5.00)

−7.58 (−11.04 to −4.12)

−2.27 (−6.33 to 1.78)

−25.76 (−29.25 to −22.27)

7.89 (3.99 to 11.78)

5.68 (1.78 to 9.59)

5.05 (4.67 to 5.44)

3.06 (2.70 to 3.42)

 Surgery

7.10 (5.34 to 8.85)

4.48 (2.77 to 6.20)

4.22 (2.21 to 6.23)

2.27 (0.54 to 4.00)

−4.81 (−6.74 to −2.88)

−3.29 (−5.22 to −1.35)

0.39 (0.21 to 0.57)

0.40 (0.23 to 0.58)

 Radiotherapy

−0.44 (−2.01 to 1.14)

−0.27 (−1.81 to 1.27)

0.13 (−1.68 to 1.94)

0.10 (−1.45 to 1.66)

1.35 (−0.39 to 3.08)

0.53 (−1.21 to 2.27)

1.11 (0.94 to 1.28)

1.05 (0.89 to 1.20)

 Chemotherapy

−3.47 (−5.29 to −1.65)

−0.58 (−2.36 to 1.20)

−1.56 (−3.65 to 0.52)

−1.20 (−3.00 to 0.59)

−0.45 (−2.45 to 1.56)

0.41 (−1.60 to 2.42)

0.93 (0.74 to 1.12)

1.02 (0.84 to 1.20)

No. of pre-existing chronic conditions

−2.32 (−3.44 to −1.19)

−2.51 (−3.61 to −1.41)

−2.92 (−4.21 to −1.63)

−0.22 (−1.33 to 0.89)

2.30 (1.06 to 3.54)

3.41 (2.17 to 4.65)

1.17 (1.06 to 1.29)

1.13 (1.02 to 1.24)